Jubilant Pharmova has informed that the Board of Directors of the Company has, at its meeting held today on Friday, October 25, 2024 at 10:30 am that concluded at 12:10 pm approved Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter and half year ended on September 30, 2024.
The above information is a part of company’s filings submitted to BSE.